Procept BioRobotics 

$25.18
364
+$0.35+1.41% Tuesday 20:00

Statistics

Day High
25.27
Day Low
24.25
52W High
65.05
52W Low
21.71
Volume
893,394
Avg. Volume
-
Mkt Cap
1.42B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.56
-0.48
-0.4
-0.32
Expected EPS
-0.457
Actual EPS
N/A

Financials

-31.02%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
616.11MRevenue
-191.14MNet Income

Analyst Ratings

36.22Average Price Target
The highest estimate is 62.00.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
70%
Hold
20%
Sell
10%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PRCT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap162.13B
Intuitive Surgical is a leading developer of robotic-assisted surgical systems, directly competing in the medical robotics space with Procept BioRobotics' AquaBeam Robotic System for prostate surgery.
Medtronic
MDT
Mkt Cap102.71B
Medtronic offers robotic-assisted surgical solutions, including its Hugo™ robotic-assisted surgery system, competing in the broader field of surgical robotics.
Smith & Nephew
SNN
Mkt Cap13.3B
Smith & Nephew provides advanced surgical robotics for orthopedics, competing in the medical robotics market albeit in a different specialty.
Zimmer Biomet
ZBH
Mkt Cap16.05B
Zimmer Biomet Holdings, Inc. competes in the surgical robotics market with its ROSA® Robot, focusing on orthopedic surgery, showing the breadth of competition in robotic surgery.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its subsidiary Ethicon, is developing robotic surgery solutions, posing competition in innovation and market share in surgical robotics.
Boston Scientific
BSX
Mkt Cap83.97B
Boston Scientific Corporation competes in the medical devices sector, including endoscopy and urology, areas relevant to Procept BioRobotics' focus.
Sensus Healthcare
SRTS
Mkt Cap65.52M
Sensus Healthcare focuses on non-invasive treatments, offering alternative solutions in the broader scope of medical treatments, including therapies that could compete with surgical interventions.
Globus Medical
GMED
Mkt Cap12.39B
Globus Medical, Inc. specializes in musculoskeletal solutions, including robotic surgery systems, indicating competition in the medical robotics field.
Stryker
SYK
Mkt Cap112.88B
Stryker Corporation is a leader in medical technology, including robotic surgical systems like Mako, competing across various surgical disciplines.

About

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
Show more...
CEO
Mr. Larry L. Wood
Employees
756
Country
United States
ISIN
US74276L1052

Listings

0 Comments

Share your thoughts

FAQ

What is Procept BioRobotics stock price today?
The current price of PRCT is $25.18 USD — it has increased by +1.41% in the past 24 hours. Watch Procept BioRobotics stock price performance more closely on the chart.
What is Procept BioRobotics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Procept BioRobotics stocks are traded under the ticker PRCT.
Is Procept BioRobotics stock price growing?
PRCT stock has risen by +15.98% compared to the previous week, the month change is a +5.89% rise, over the last year Procept BioRobotics has showed a -52.7% decrease.
What is Procept BioRobotics market cap?
Today Procept BioRobotics has the market capitalization of 1.42B
When is the next Procept BioRobotics earnings date?
Procept BioRobotics is going to release the next earnings report on July 30, 2026.
What were Procept BioRobotics earnings last quarter?
PRCT earnings for the last quarter are -0.56 USD per share, whereas the estimation was -0.56 USD resulting in a +0.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Procept BioRobotics revenue for the last year?
Procept BioRobotics revenue for the last year amounts to 616.11M USD.
What is Procept BioRobotics net income for the last year?
PRCT net income for the last year is -191.14M USD.
How many employees does Procept BioRobotics have?
As of May 06, 2026, the company has 756 employees.
In which sector is Procept BioRobotics located?
Procept BioRobotics operates in the Health & Wellness sector.
When did Procept BioRobotics complete a stock split?
Procept BioRobotics has not had any recent stock splits.
Where is Procept BioRobotics headquartered?
Procept BioRobotics is headquartered in San Jose, United States.